NCT00392392 - Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

December 31, 2011

Conditions

Breast Cancer

Interventions

DRUG

nab-paclitaxel

ABI-007

DRUG

Bevacizumab

DRUG

Trastuzumab

Trial Locations (6)

Northeast Georgia Medical Center, Gainesville

Florida Hospital Cancer Institute, Orlando

Florida Cancer Specialists, Fort Myers

Tennessee Oncology, PLLC, Nashville

Chattanooga Oncology Hematology Associates, Chattanooga

Grand Rapids Clinical Oncology Program, Grand Rapids